Catalent To Expand Clinical Supply Facility in Singapore
Catalent Pharma Solutions plans to invest $4.6 million to further expand its Singapore clinical supply facility by building new flexible GMP space for secondary packaging, doubling its ambient storage space, and quadrupling cold-storage capacity. The continued expansion of the site will support global and regional customers' growth in clinical trials activity in the Asiaâ€“Pacific region.
Established in 1998, Catalent's Singapore site now provides full clinical supply services including project and supply chain management, comparator sourcing, clinical label printing, secondary packaging, clinical storage, import/export management, importer of record (IoR) service, and full returns and destruction management services. It has served as a regional hub for studies in Australia, Singapore, Korea, Hong Kong,and other countries in Southeast Asia.
Catalent’s clinical supply services has facilities in the US, UK, Germany, Japan, and China.
Source: Catalent Pharma Solutions